Glucose-lowering effects and low risk of hypoglycemia in patients with maturity-onset diabetes of the young when treated with a GLP-1 receptor agonist: a double-blind, randomized, crossover trial - Østoft, SH; Bagger, JI; Hansen, T (Diabetes Care, 2014)
et al.